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Background—Substance use is associated with HIV sexual risk behaviors, yet few studies have
examined substance use patterns longitudinally. We evaluated the types and frequency of
substances used over a six-month period among U.S. women at risk for HIV acquisition.
Methods—Women reporting unprotected sex with a man in the previous six months and at least
one other personal or partner HIV risk characteristic enrolled in a multisite cohort study and
completed interviews about substance use at study visits. Prevalence and frequency of substance
use at the baseline and six-month visits were compared and correlates of decreased substance use
at the six-month visit were assessed.
Results—Of 2,099 women enrolled, 1,882 had substance use data at baseline and six-months. Of
these, 76.1% reported using at least one drug or binge drinking in the previous six months; 37.5%
were frequent and 38.6% non-frequent substance users. Binge drinking was most frequently
reported (63.3%), followed by cocaine (25.0%) and opioids (16.5%). Fifty-five percent of opiate
users and 30% of cocaine users reported daily/almost daily use. At the six-month visit, 40.5%
reported a decrease in frequency of use. Adjusting for income and type of drug used, poly-
substance users were less likely to decrease frequency of use compared to those who only used
one substance.
Conclusion—A substantial decrease in frequency of substance use over time was observed in
this cohort. Poly-substance users were less likely to reduce frequency of use over time, suggesting
that specific substance use interventions targeting these users are warranted.
Keywords
women; substance use; opiate use; cocaine use; binge drinking; HIV
1. Introduction
In 2010, 28% of all newly reported HIV cases nationally were attributed to heterosexual
transmission (Centers for Disease Control and Prevention (CDC), 2012a). Among women,
the vast majority of reported cases (86%) were attributed to heterosexual sex (CDC, 2012a).
Significant racial disparities also exist for newly reported cases among women. Of the total
number of new HIV infections among women in the United States in 2010, 64% occurred in
blacks/African Americans, more than three times that of white women (18%; CDC, 2013.
Similarly, the overall new case rate per 100,000 for the general female adult and adolescent
population is 8.0 per 100,000, yet the rate for black/African-American women is 41.7 per
100,000, nearly 20 times as high as white females (2.1 per 100,000) and approximately four
and half times as high as Hispanic/Latino females (9.2 per 100,000; CDC, 2012b).
Substance use (both drugs and alcohol) has been consistently found to be associated with
risky sexual behaviors (Hutton et al., 2012; Patrick et al., 2012; Stein et al., 2005), including
concurrent sexual partnerships (Adimora et al., 2003, 2011) and low or no condom use
(Ober et al., 2011; Patrick et al., 2012), as well as sexually transmitted infections, including
HIV (Edlin et al., 1994; McClelland et al., 2007; Nijhawan et al., 2011; NIMH Multisite
HIV/STD Prevention Trial for African American Couples Group, 2010; Seth et al., 2011;
Sterk et al., 2003; Van Der Pol et al., 2008). Low income has been found to be associated
with elevated prevalence of viral infections and HIV (Dinenno et al., 2012; Stover et al.,
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2003), and research on neighborhood characteristics and substance misuse suggests a
positive association between economic disadvantage and the use of alcohol and other drugs
(Boardman et al., 2001; Cohen et al., 2003; Jones-Webb et al., 1997; Theall et al., 2009;
Williams et al., 2007).
Although much research has studied substance use among women at high risk for HIV
infection, few have examined changes in substance use over time and the factors that drive
those changes. Several studies examining substance use behaviors among women at high
risk for HIV have been conducted within the Women's Interagency HIV Study (WIHS)
cohort. Baseline data from WIHS revealed a high prevalence of drug use, with 28.9% of
cohort participants reporting drug use in the previous six months, and among those who
were HIV-negative, 25% reported crack use, 19.7% reported cocaine use, and 10.3%
reported injection drug use at baseline (Wilson et al., 1999). Two studies of longitudinal
patterns of drug use were conducted using WIHS data, but both focused on marijuana use,
and one was conducted among HIV-positive participants only (D'Souza et al., 2012; W. H.
Kuo et al., 2004). In a different longitudinal study, Warner et al. found that among crack and
cocaine using women in Puerto Rico, those who traded sex for money and exhibited
depressive symptoms were less likely to experience remission of drug dependence
symptoms (Warner et al., 2004). This study, however, was limited by its small sample size
and lack of broader generalizability beyond its one unique geographic location. Therefore,
there is a need to assess more complex substance use patterns, changes in the frequency of
use over time, or the factors that may be driving these changes within a geographically
diverse group of women at risk for HIV.
We examined data from the HIV Prevention Trials Network (HPTN) 064 The Women's HIV
SeroIncidence Study. The purpose of HPTN 064 was to evaluate HIV incidence among US
women living in geographic areas with high rates of poverty and HIV prevalence and to
assess factors that may increase HIV acquisition risk. HIV annual incidence in the HPTN
064 cohort (consisting of predominantly African American women) was 0.32% (Hodder et
al., 2013), nearly six-fold higher than that estimated for the general population of African
American women of similar age (Prejean et al., 2011). Baseline substance use was found to
be significantly associated with baseline HIV infection in HPTN 064 (Hodder et al., 2013).
The objective of this study was to analyze substance use patterns in a large, geographically
diverse cohort of women at increased risk for HIV acquisition. We examined the types and
frequency of substances used in the baseline cohort and the changes in the frequency of use




As previously described (Hodder et al., 2013), HPTN 064 was a multi-site, longitudinal
cohort study enrolling women between May 2009 and July 2010. The study sample was
drawn from 10 urban and peri-urban communities with a high prevalence of poverty and
HIV prevalence located in the Northeastern and Southeastern US. Previous descriptions of
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the locations and sampling strategy have been published elsewhere (Hodder et al., 2013).
Approximately 210 women were recruited from each community. Venue-based sampling
was used to recruit women who attended specific locations within defined geographic areas.
In brief, index scores for census tracts in the 10 communities were developed using an
algorithm including poverty rate based on census data and/or zip codes (used in New York
City) and HIV/AIDS prevalence based on local public health surveillance data. We
identified the venues in the top 30% ranking census tracts that are frequented by women
who potentially would be eligible to participate. Venues and corresponding recruitment
times were randomly selected each month; women were approached systematically at these
venues to be screened for study eligibility. Eligible individuals resided in these identified
census tracts/zip codes, were 18 to 44 years of age, self-identified as a woman, reported at
least one episode of unprotected vaginal and/or anal sex with a man in the six months before
enrollment as well as an additional personal or partner HIV risk characteristic, and were
willing to undergo HIV rapid testing and receive HIV test results. Women were followed for
six or 12 months, depending on time of enrollment, as previously described (Hodder et al.,
2013). The HPTN 064 study was approved by institutional review boards at all study sites
and collaborating institutions. A Certificate of Confidentiality was obtained for the study.
Participants underwent HIV testing and audio computer-assisted self-interviews (ACASI) at
entry to the study and at six-month intervals for up to 12 months. The baseline and six
month ACASI, which collected self-reported demographic, behavioral (sexual and substance
use behaviors) and psychosocial data, were the data sources for this analysis. Sexual risk
behaviors assessed included number of sexual partners in the last six months, condom use,
exchange of sex for money, drugs and/or goods/services, and self-reported direct
concurrency, which was defined as the participant reporting that she had overlapping sexual
partnerships in the past six months. Other behaviors and experiences included incarceration
for at least 24 hours within the previous five years, depressive symptomatology (assessed
using the CES-D-8, in which a score of ≥7 of 32 on an eight-item four point scale was
positive for depressive symptoms) (DiClemente et al., 2001; Melchior et al., 1993) and post-
traumatic stress disorder (PTSD) using the four-question Primary Care PTSD screener (Prins
et al., 2003), in which a score ≥3 (at least three out of four) suggested an increased
likelihood of a PTSD diagnosis. Incarceration history was assessed through an eligibility
screener prior to enrollment.
2.2 Definition of Substance Use
Self-reported substance use (drug use and/or binge drinking) in the previous six months was
assessed using a modified World Health Organization ASSIST scale (World Health
Organization ASSIST Working Group, 2002). Past six-month use of substances was
assessed individually and included: alcohol (binge drinking defined as four or more drinks in
one sitting), opioids, cocaine, amphetamine-type stimulants, inhalants, sedatives/sleeping
pills, and hallucinogens. Cannabis use was assessed, but due to lack of evidence regarding
its association with HIV risk (Logan et al., 2000; Smith et al., 2010), it was excluded from
this analysis. Based on major subclasses of drugs identified by Friedman (Friedman et al.,
2003) and distribution of use across the sample, we defined six hierarchical and mutually
exclusive categories of substance use as (from highest to lowest level of HIV riskiness) 1)
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opioid use; 2) cocaine use (including crack and powdered cocaine); 3) amphetamine use; 4)
sedative/sleeping pill use; 5) use of inhalants, hallucinogens, or other drugs; and 6) binge
drinking. For example, if a participant reported using opioids and amphetamines, she would
be classified as being an opiate user, which is the higher of the two risk categories. We
applied a similar hierarchical substance use categorization in a previous study (Kuo et al.,
2011).
The prevalence of use in the past six months was calculated for each of the six substance
categories for the total study population. We assessed the use of multiple substances during
the recall period in two different ways. To present information on the types (versus number)
of drugs used during the recall period, for each drug class, we calculated the proportion of
individuals who used each of the other classes of substances (e.g., of opioid users, 66.1%
also used cocaine), as has been done previously (Kuo et al., 2011). In addition, a more
conventional presentation of the use of multiple substances is presented as the number of
different substances a participant reported using in the previous six months, categorized as
either one, two, three or four or more substances used.
2.3 Frequency of substance use
For this analysis, only women who reported using any substance (excluding cannabis) at
baseline were included. For each substance used during the prior six months, substance use
frequency was categorized as 1) daily to less than weekly, 2) weekly, 3) monthly or 4) once
or twice (<monthly). The substance most frequently used by a woman in the previous six
months was considered the “drug of choice” and was used to categorize each person
regarding drug use frequency. Therefore, individuals who used more than one substance
were categorized based on the drug used most frequently during the recall period. If an
individual reported using multiple drugs at the same frequency, then a decrease in frequency
of any of the drugs reported was counted as a decrease in frequency.
To assess changes in substance use frequency between baseline and the six month study
visit, the frequency of substance use was further collapsed and categorized as 1) frequent
substance use (defined as daily to weekly use of any illicit drug and/or weekly binge
drinking); 2) non-frequent substance use (defined as less than weekly use of illicit drugs
and/or monthly binge drinking); 3) non-use (those who did not use any illicit drugs or binge
drink). Since only women who used drugs at baseline were included in this analysis, the
non-use category is applicable at the six month follow-up visit only. The frequency of drug
use was compared across the two visits. Individuals were categorized as decreasing
substance use if their frequency changed from frequent to non-frequent use or to no
substance use. Individuals with non-frequent substance use at baseline who reported no
substance use at the six-month visit were also categorized as decreased substance use. All
others including those who used at the same frequency or increased their usage frequency
were categorized as not having decreased substance use.
2.4 Data analysis
Data analysis was conducted in three phases. First, descriptive characteristics were
calculated and presented by frequency of drug use for the entire study population, including
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those who did not use drugs. Second, to describe the extent of multiple substances used in
the sample, the prevalence of substance use and poly-substance use was calculated based on
the aforementioned hierarchical categorization among the women who reported any
substance use at baseline. Third, we calculated the proportion of women who reported
decreased substance use from baseline to the six month follow-up visit. Bivariate log
regression and relative risks were used to describe baseline predictors associated with
decreased substance use over time. Multivariable log regression analysis was conducted
adjusting for all variables significant at p<0.10 in the bivariate analyses. Variables attaining
p≤0.05 were retained in the model and considered to be statistically significant. All analyses
were conducted using SAS version 9.2 (SAS Inc., NC).
3. Results
Of the 2,099 women enrolled, 89.7% (n=1,882) had complete data on substance use at the
baseline and six-month visits. Of these, 23.9% did not report using any substances at the
baseline visit, while 76.1% (n=1,432) reported using at least one of the substances or binge
drinking in the previous six months, of which 37.5% were frequent substance users and
38.6% were non-frequent substance users (Table 1). Compared to non-frequent users and
non-users, frequent substance users were significantly older, less educated and earned less
money. Frequent users were also more likely to have had more than one sex partner in the
past six months, reported concurrent partnership, had a male partner who used drugs, had
anal sex, and exchanged sex for commodities in the past six months. These women were
also more likely to have been incarcerated, report depressive symptoms, and screen positive
for PTSD.
The most prevalent substance used was alcohol, with 63.3% of the study population
reporting binge drinking in the six months prior to enrollment, followed by cocaine use
(25.0%) and opioid use (16.5%; Table 1). Approximately one in ten women reported using
amphetamines (10.8%). Nearly the same proportion used sedatives/sleeping pills (10.1%).
The prevalence of opioid and cocaine, sedative/sleeping pill, and inhalant, hallucinogen or
other drugs was higher among frequent users versus non-frequent users. However, the
prevalence of binge drinking among the non-frequent users was higher compared to frequent
users, although it was high in both groups (86.4% versus 79.9%, p=0.002). Frequent users
were also significantly more likely to report using more than one substance than non-
frequent users (62.9% versus 24.8%, p=<.0001). Of the women included in this analysis,
overall 43%b reported using only one substance in the past six months at baseline, while
more than one-third reported using two or more substances during that time period.
Table 2 describes the use of multiple substances across the different substance use groups
reported at baseline. Among the women who reported using any substances in the six
months prior to enrollment, 66% of opioid users also reported using cocaine, and 33%
reported using sedatives or sleeping pills. Among those who used cocaine, 44% also used
opioids, 24% used sedatives or sleeping pills, and 15% used amphetamines. Overall, the
prevalence of binge drinking was high across each of the drug use groups, ranging from
56% among opiate users to 84% among amphetamine users. Opiate users reported the
highest frequency of illicit substance use, with 54.5% of opiate users reporting daily or
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almost daily opiate use, compared with only 30% of cocaine users reporting daily cocaine
use. In contrast, the majority of amphetamine users (60.1%), sedative/sleeping pill users
(44.2%) and inhalant/hallucinogen users (40.7%) used only once or twice in the past six
months. Frequency of binge drinking was somewhat evenly distributed, with most binge
drinkers (36.0%) reporting binge drinking only once or twice in the past six months,
compared with 13.5% who reported daily or almost daily binge drinking.
At the six-month visit, 40.5% of those who reported any substance use at baseline reported a
decrease in the frequency of use of the substance most frequently used at baseline, versus
59.5% who did not report a decrease in use (Table 3). On a bivariate level, individuals who
decreased the frequency of substance use over time were more likely to have earned $10,000
or less at baseline (relative risk [RR]: 1.28; 95% confidence interval [CI]: 1.00, 1.63),
although this was borderline statistically significant. Opioid users were less likely to
decrease their frequency of substance use over time versus non-opioid users (RR: 0.86; 95%
CI: 0.73, 1.01), which was also marginally statistically significant. Individuals who reported
using four or more substances at baseline were significantly less likely to report a decrease
in the frequency of use compared to those who only reported using one substance (RR: 0.72;
95% CI: 0.53, 0.97). Other characteristics, such as demographics, sexual behaviors,
incarceration history, depression and PTSD were not significantly associated with decreased
substance use over time. In the multivariable regression model, the number of substances
used at baseline was the only independent predictor of reducing frequency of use: those who
used two substances or four or more substances were less likely to reduce their substance
use frequency compared to those who only used one (aRR=0.64 (0.42, 0.98) and aRR=0.22
(0.05, 1.00), respectively), adjusted for income and type of substance used.
4. Discussion
In this cohort of community-recruited women from areas of high HIV/AIDS case prevalence
and poverty, a high prevalence of drug and alcohol use was observed. The prevalence of
substance use in this study is much higher than national estimates of drug use and alcohol
consumption in the general U.S. population (Compton et al., 2007; Hasin et al., 2007) and,
in part, may reflect the study's inclusion criterion of substance use in the past six months.
Our estimates are comparable, however, to cross-sectional estimates from other studies of
US women at risk for HIV, including those using similar recruitment methods, after
excluding binge drinking (Jenness et al., 2010; Lillie-Blanton et al., 2010; Richards et al.,
2008; Wilson et al., 1999). Alcohol, specifically binge drinking, was the most prevalent
substance used in our study, with nearly two-thirds of women reporting binge drinking in the
six months prior to enrollment and, among these, more than one-third reported binge
drinking on a daily to weekly basis. The estimate of binge drinking in our study far exceeds
the prevalence (21%) estimate among rural African-American and Hispanic women in the
Southeast US (McLellan-Lemal et al., 2012), and exceeds estimates reported in studies of
women at risk for HIV using similar recruitment methods as part of National HIV
Behavioral Surveillance (Jenness et al., 2010; Neaigus et al., 2012). Binge drinking is
associated with high risk sexual behaviors related to HIV transmission, such as inconsistent
condom use (Richards et al., 2008); and unprotected anal intercourse (McLellan-Lemal et
al., 2012), suggesting the women in our study are also at risk for HIV due to high prevalence
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of reported binge drinking. As reported previously (Hodder et al., 2013), formal statistical
assessment of binge drinking as a predictor of HIV incidence in our study was not possible
due to the small number of incident cases.
In addition, a substantial decrease in the frequency of substance use over time was observed.
Women who used multiple substances were less likely to reduce their substance use
frequency during the follow-up period. The use of multiple substances may suggest a higher
level of dependence compared to those who use only one substance; this in turn may explain
the lower likelihood of reducing substance use frequency over a six month period among
poly-substance users. In a longitudinal study among low-income cocaine and crack using
women in Puerto Rico, a similar decrease in drug dependence symptoms was also seen over
a similar time period (Warner et al., 2004). However, the factors negatively associated with
remission of drug dependence symptoms in that study (trading money for sex or drugs,
depressive symptoms and drug abuse treatment (Warner et al., 2004)) differed from our
study, in which using more than one substance was the only independent factor associated
with frequency of use; these differences may be a result of geographic differences or
differences in measures of reduced substance use. Remission of alcohol and drug use can
occur spontaneously or with engagement in drug or substance use treatment; our study did
not assess treatment experience during the follow-up period, which could have explained the
decrease in use observed in our population. Low income was also associated with a decrease
in frequency of use, suggesting that economic reasons may be driving the behavior change
as has been seen in previous research (Corman et al., 2005; Dave, 2006); however, we were
unable to explain this further since our study was not designed to explore the role of
personal resource constraints on substance use behavior.
Other potential explanations for the decrease observed in this cohort include exposure to
HIV pre- and post-test counseling, access to educational prevention materials, and receipt of
referrals to local resources and care, including substance abuse treatment programs, as part
of the study protocol. Although HPTN 064 was not an intervention-based study, perhaps
exposure to HIV prevention messaging precipitated the decrease in actual or self-reported
use. In addition, it is also plausible that because the baseline of substance use frequency was
high from the start, part of the decrease observed could be attributed to a “regression to the
mean” (Campbell et al., 2007). Alternatively, participants may have under-reported
substance use at the follow-up visits due to socially-desirable reporting. Study staff
conducted monthly check-in calls to support retention efforts for the study and were able to
develop a close rapport with many of the study participants, which may have driven the
desire to report more positive behaviors or acted as an intervention in itself. However, the
use of ACASI for data collection likely mitigated some of this bias, (Macalino et al., 2002;
Metzger et al., 2000), and therefore it is difficult to determine whether socially-desirable
reporting is a true explanation for this decrease in substance use frequency.
Other limitations to this study should be noted. Although we used a standardized measure of
substance use, substance abuse and dependence was not formally assessed, and it was not
possible to determine whether these declines in substance use frequency would be reflected
as changes in actual abuse/dependence status. In addition, due to lack of sample size for
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subgroup analyses, we were unable to examine substance use trajectories within separate
categories of substance use (i.e., opiate users versus cocaine users).
There were also several strengths in this study. First, this is the first longitudinal study to our
knowledge that has focused on decreases in the frequency of substance use, rather than
cessation or remission from drug use. Although one may argue that the ultimate goal of
recovery from substance use is cessation, reductions in drug use and associated harms
related to substance use have also been shown be effective in reducing HIV risk behaviors
among drug using populations (Metzger et al., 1993, 2010; Ross et al., 2007; Rotheram-
Borus et al., 2010). In addition, a high level of retention in this cohort study was achieved,
with 93% being retained at the six-month visit. Lastly, the sample is geographically diverse
and was recruited through venue-based sampling techniques, different from other
longitudinal studies, which used word-of-mouth and convenience sampling (Warner et al.,
2004; Wilson et al., 1999). It should be noted that women were not required to be a
substance user to be eligible for the study, although substance use was one of several
“personal risk characteristics” the women could have met to be included in the study;
because of this, these substance use prevalence estimates may not be representative of
women at high risk for HIV in general. However, our prevalence estimates do reveal a
strikingly high level of substance use among women recruited from these diverse, yet
impoverished locations that far exceed the general population, suggesting a critical need for
interventions to reduce substance use problems among such women, given the demonstrated
link between substance use and HIV risk.
In conclusion, a large proportion of low-income women recruited from communities deeply
affected by HIV reported frequent engagement in drug use and binge drinking at the time of
their participation in this study. It is clear that this population is in great need of effective
interventions to reduce the burden of substance use and associated risk for HIV infection,
including that from binge drinking. Although declines in the frequency of substance use
over time were observed, this was only seen among those with a lower burden of substance
use; a better understanding of the drivers of this decrease in use is needed in order to build
culturally and gender-appropriate behavioral interventions. Further quantitative and
qualitative data are critical to understand the patterns of substance use and factors associated
with decision making regarding consumption and engaging in HIV risk.
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Table 3
Bivariate associations of decreased substance use* from baseline to the six month visit in
HPTN 064 (N=1,432)
Baseline Characteristics Decreased use N=580
Did not decrease use
N=852
RR for Decreased Use (95%
CI)
Age (years) (vs 18-24)
 25 – 35 195 (33.6%) 323 (37.9%) 0.88 [0.75, 1.03]
 36 + 216 (37.2%) 305 (35.8%) 0.96 [0.83, 1.12]
Race (vs non-African-American)
 African American 505 (87.1%) 726 (85.2%) 1.10 [0.91, 1.33]
Education (vs <high school)
 High school or higher 369 (63.6%) 536 (62.9%) 1.02 [0.89, 1.16]
Household income (vs. ≥$20,000)
 $10,000 or less 286 (49.3%) 358 (42.0%) 1.28 [1.00, 1.63]
 $10,001 to $20,000 55 (9.5%) 115 (13.5%) 0.93 [0.68, 1.27]
 Refused to answer/Don't know 191 (32.9%) 289 (33.9%) 1.14 [0.89, 1.47]
2+ partners in past 6 months (vs ≤1†) 351 (61.0%) 540 (64.1%) 0.93 [0.82, 1.05]
Concurrent partnership (self-reported) 232 (40.1%) 359 (42.3%) 0.95 [0.83, 1.08]
Had male partner who used drugs past 6 months 240 (41.4%) 351 (41.2%) 1.00 [0.88, 1.14]
Did not Use condom last vaginal sex 484 (84.3%) 705 (83.6%) 1.03 [0.87, 1.23]
Had anal sex in past 6 months 230 (39.7%) 336 (39.5%) 1.01 [0.88, 1.14]
Exchanged sex for commodities in past 6 months 242 (42.1%) 360 (42.7%) 0.99 [0.87, 1.12]
Incarcerated in past 5 years 252 (43.4%) 366 (43.0%) 1.01 [0.89, 1.15]
Depressive Symptoms 209 (38.5%) 330 (41.2%) 0.93 [0.82, 1.07]
Screened positive for post-traumatic stress disorder 177 (31.2%) 284 (33.8%) 0.93 [0.81, 1.07]
Substance used in past 6 months±
 Opioid 111 (19.1%) 199 (23.4%) 0.86 [0.73, 1.01]
 Cocaine 177 (30.5%) 294 (34.5%) 0.90 [0.78, 1.03]
 Amphetamines 78 (13.4%) 125 (14.7%) 0.95 [0.79, 1.15]
 Sedative or Sleeping Pills 68 (11.7%) 122 (14.3%) 0.88 [0.72, 1.08]
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Baseline Characteristics Decreased use N=580
Did not decrease use
N=852
RR for Decreased Use (95%
CI)
 Inhalants, Hallucinogens, or Other 36 (6.2%) 45 (5.3%) 1.12 [0.87, 1.44]
 Binge drinking 476 (82.1%) 715 (83.9%) 0.94 [0.8, 1.11]
Number of substances used (vs 1)
2 substances 145 (25.0%) 236 (27.7%) 0.88 [0.76, 1.02]
3 substances 54 (9.3%) 89 (10.5%) 0.87 [0.70, 1.09]
4+ substances 21 (5.3%) 69 (8.1%) 0.72 [0.53, 0.97]
RR = Relative Risk
*
Decreased use based on reduced frequency of use of the substance used most frequently at baseline.
†
Two women reported having zero male sex partners in the previous six months.
±
Reference group = non-users of each particular drug.
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